InsiderClue
Stocks · Health care · Pharmaceutical Preparations

UroGen Pharma Ltd.

URGN Clue Score39
Israel Fiscal year ends December CIK 0001668243 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

15
Insider
Date
Role
Action
Shares
Price
Amount
Chris Degnan
8 Oct 2026
Chief Financial Officer
Sold after exercise
2,202
$36.69
$80.79K
Jason Drew Smith
8 Sep 2026
General Counsel
Sell
1,519
$42.54
$64.62K
Mark Schoenberg
8 Sep 2026
Chief Medical Officer
Sell
871
$42.92
$37.38K
Mark Schoenberg
20 Aug 2026
Chief Medical Officer
Sell
60,677
$47.05
$2.85M
Mark Schoenberg
9 Jul 2026
Chief Medical Officer
Sold on a plan
10,000
$40.00
$400.00K
Mark Schoenberg
22 Jun 2026
Chief Medical Officer
Sold on a plan
10,000
$35.01
$350.10K
Mark Schoenberg
8 Jun 2026
Chief Medical Officer
Sold after exercise
5,222
$27.30
$142.56K
Mark Schoenberg
8 May 2026
Chief Medical Officer
Sold on a plan
10,000
$30.00
$300.00K
Mark Schoenberg
3 Feb 2026
Chief Medical Officer
Sell
3,686
$19.69
$72.58K
Mark Schoenberg
3 Feb 2026
Chief Medical Officer
Sell
1,843
$19.69
$36.29K
Mark Schoenberg
3 Feb 2026
Chief Medical Officer
Sell
1,844
$19.69
$36.31K
Jason Drew Smith
3 Feb 2026
General Counsel
Sell
3,217
$19.69
$63.34K
Jason Drew Smith
3 Feb 2026
General Counsel
Sell
1,608
$19.69
$31.66K
Jason Drew Smith
3 Feb 2026
General Counsel
Sell
2,654
$19.69
$52.26K
Mark Schoenberg
19 Nov 2025
Chief Medical Officer
Sold on a plan
10,000
$25.00
$250.00K

What was left out

Form 4 filings counted 28
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 2
Sales at will 9
Transactions with no price 0
Shares from compensation/vesting 62,317
History held since 29 Nov 2017